PARP-1 抑制剂的计算设计:QSAR,分子对接,虚拟选,ADMET和分子动力学模拟用于向药物开发
1Laboratory of Chemometrics, Faculty of Chemistry, University of Mazandaran, Babolsar, Iran.
SAR and QSAR in environmental research
|April 28, 2025
概括
研究人员使用fthalazinone支架确定了新的Poly (ADP-ribose) 聚合酶-1 (PARP-1) 抑制剂. 这些化合物显示出治疗具有DNA修复缺陷的癌症的巨大潜力,包括乳腺癌和卵巢癌.
科学领域:
- 药用化学 医学化学
- 计算化学计算化学
- 在瘤学瘤学.
背景情况:
- 多 (ADP-ribose) 聚合酶-1 (PARP-1) 抑制剂对具有同源重组修复缺陷的癌症有效,例如BRCA1/2-突变的乳腺癌和卵巢癌.
- 弗他拉津支架因其在PARP-1活性位点内形成强有力的和选择性的相互作用的能力而闻名.
研究的目的:
- 为了发现和优化使用fthalazinone支架的新型PARP-1抑制剂.
- 通过计算方法评估新设计的化合物的抗癌潜力.
主要方法:
- 量化结构-活动关系 (QSAR) 建模,包括多重线性回归 (MLR) 和支持向量机 (SVM),用于预测抑制活性.
- 进行了分子对接模拟,以评估化合物与PARP-1活性部位的结合相互作用.
- 虚拟选和分子动力学 (MD) 模拟被用于识别和验证化合物.
主要成果:
- MLR和SVM模型显示了对PARP-1抑制的高预测准确性 (MLR:R 2=0.944,Q 2=0.921;SVM:R 2=0.947,Q 2=0.887).
- 几种新型化合物在PARP-1活性部位表现出与关键残留物 (GLY227A,MET229A,PHE230A,TYR246A) 的强有力的结合相互作用,与已知的抑制剂相当.
- 对排名第一的化合物 (3a) 的200 ns MD模拟证实了在生理条件下稳定的结合和维持的分子间相互作用.
结论:
- 甲松基架是开发新型PARP-1抑制剂的有希望的基础.
- 计算方法有效地识别了针对PARP-1的强效抗癌化合物.
- 化合物 (3a) 显示出良好的结合稳定性,需要进一步研究癌症治疗.
相关概念视频
Structure-Activity Relationships and Drug Design
429
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
429
Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K


